NMPA to Further Implement the Measures for the Supervision and Management of Drug Distribution and Use Quality

On December 22, 2023, the National Medical Products Administration (NMPA) issued the Guidelines on Soliciting Public Opinions on the Implementation of the Measures for the Supervision and Administration of Drug Distribution and Use Quality (the “Measures”), to further implement the requirements of the Measures and regulate drug distribution behaviors.

The document clarifies that drug regulatory authorities at all levels must make full use of technological means such as 5G networks, big data, and artificial intelligence to achieve iterative upgrades of drug circulation market elements, structures, processes, and services, and focus on vaccines, anesthetics, psychotropic drugs, selected drugs for centralized procurement, biological products, botulinum toxin type A for injection, and other drug varieties to accelerate the IT-based traceability of drugs.